GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease

Author:  ["Katsuhiko Yanagisawa","Asano Odaka","Nobuhiro Suzuki","Yasuo Ihara"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

The earliest event so far known that occurs in the brain affected with Alzheimer's disease (AD) is the deposition and fibril formation of amyloid β–protein (Aβ). Aβ is cleaved from a glycosylated membrane protein, called β–amyloid protein precursor, and normally secreted into the extracellular space. Here we report on the presence of membrane–bound Aβ that tightly binds CM1 ganglioside. This suggests that this novel Aβ species, rather than secreted Aβ, may act as a ‘seed’ for amyloid and further that intracellular abnormalities in the membrane recycling already exist at the stage of amyloidogenesis

Cite this article

Yanagisawa, K., Odaka, A., Suzuki, N. et al. GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease. Nat Med 1, 1062–1066 (1995). https://doi.org/10.1038/nm1095-1062

View full text

>> Full Text:   GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease

The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, parti